AbbVie Gains on Moody's Credit Upgrade, Focus Shifts to Immunology Portfolio
Markets Daniel Marsh

AbbVie Gains on Moody's Credit Upgrade, Focus Shifts to Immunology Portfolio

AbbVie shares rose 2% to $223.43 after Moody's upgraded its credit rating to A2 with a stable outlook. Investors now watch demand and pricing for Skyrizi and Rinvoq amid Humira competition.

ABBV
Micron Rises on UBS Target Hike Amid HBM4 Supply Concerns
Technology Sarah Chen

Micron Rises on UBS Target Hike Amid HBM4 Supply Concerns

Micron shares gained 3% to $394.69 after UBS raised its price target to $450, citing prolonged memory shortages. However, a separate report suggests Micron may miss out on Nvidia's next-generation HBM4 orders.

MU NVDA UBS SSNLF AMZN XLK
SK hynix Shares Dip Amid Tech Sell-Off, Dividend Dates Set
Markets Daniel Marsh

SK hynix Shares Dip Amid Tech Sell-Off, Dividend Dates Set

SK hynix closed at 839,000 won, down 0.36%, as the KOSPI fell 1.4% to end a six-week rally. The company announced a 1,875 won per share dividend with key dates in late February.

SSNLF AAPL XLK
Home Depot Earnings Preview: Inflation, Jobs Data Set Stage for Housing Demand Signals
Earnings James Calloway

Home Depot Earnings Preview: Inflation, Jobs Data Set Stage for Housing Demand Signals

Home Depot shares underperformed the broader market rally Friday as investors await key inflation and employment reports ahead of the retailer's quarterly results later this month.

HD LOW SPY
Roche's MS Drug Trial Results Spark Investor Scrutiny Ahead of Key Presentation
Markets Daniel Marsh

Roche's MS Drug Trial Results Spark Investor Scrutiny Ahead of Key Presentation

Roche's experimental multiple sclerosis drug fenebrutinib met its primary endpoint in a late-stage study but showed higher liver enzyme elevations and fatalities versus Ocrevus. Investors await Monday's detailed data webcast.

RHHBY XLV
Roche's MS Drug Trial Results Set Stage for Monday Investor Scrutiny
Markets Daniel Marsh

Roche's MS Drug Trial Results Set Stage for Monday Investor Scrutiny

Roche's fenebrutinib met its primary endpoint in a late-stage PPMS trial, showing non-inferiority to Ocrevus but with higher liver enzyme elevations and fatal cases. Shares closed at 356.40 Swiss francs, down 0.6%.

RHHBY
Chevron Shares Edge Higher Amid Oil Volatility, Insider Sale and Dividend Date
Commodities Rebecca Torres

Chevron Shares Edge Higher Amid Oil Volatility, Insider Sale and Dividend Date

Chevron stock rose 0.9% to $180.86 Friday, underperforming the broader energy sector. The company's CTO sold 6,000 shares, while investors eye the upcoming Feb. 17 dividend record date.

CVX XLE USO
Chevron Shares Edge Higher Amid Oil Volatility, Insider Sale and Dividend Date
Commodities Rebecca Torres

Chevron Shares Edge Higher Amid Oil Volatility, Insider Sale and Dividend Date

Chevron stock rose 0.9% to $180.86 Friday, underperforming the broader energy sector. Investors are monitoring oil price swings, an executive's share sale, and the upcoming February 17 dividend record date.

CVX XLE USO
Bank of America Rises with Broader Rally, Eyes on Key Economic Data
Markets Daniel Marsh

Bank of America Rises with Broader Rally, Eyes on Key Economic Data

Bank of America shares advanced 2.9% to $56.53 on Friday, joining a market surge that pushed the Dow above 50,000. Investors now await delayed U.S. jobs and inflation figures, which could influence interest rate expectations.

BAC JPM C WFC XLK XLF DIA
Bank of America Rises with Broader Rally, Eyes on Key Economic Data
Markets Daniel Marsh

Bank of America Rises with Broader Rally, Eyes on Key Economic Data

Bank of America shares advanced 2.9% to $56.53 on Friday, joining a market surge that pushed the Dow above 50,000. Investors now await delayed U.S. jobs and inflation reports for clues on interest rate policy.

BAC JPM C WFC XLK XLF
Mastercard Shares Dip as Investors Eye Executive Compensation and Upcoming Economic Data
Markets Daniel Marsh

Mastercard Shares Dip as Investors Eye Executive Compensation and Upcoming Economic Data

Mastercard shares closed lower Friday at $548.74, underperforming peers Visa and American Express. The company disclosed increased executive pay and a new dividend, while markets await key U.S. jobs and inflation reports.

MA V AXP
Mastercard Slips as Executive Pay Rises, Markets Eye Jobs Data
Markets Daniel Marsh

Mastercard Slips as Executive Pay Rises, Markets Eye Jobs Data

Mastercard shares declined 0.6% to $548.74 Friday, underperforming peers Visa and American Express. The company increased compensation for top executives and declared a quarterly dividend of $0.87 per share.

MA V AXP